Hermetica Superfood Encyclopedia
The Short Answer
Hapalopilus rutilans contains polyporic acid (comprising 20–40% of dry fruit body weight), a terphenyl quinone compound that inhibits dihydroorotate dehydrogenase (DHODH), thereby disrupting de novo pyrimidine biosynthesis in rapidly dividing cells. Despite laboratory interest in this DHODH-inhibitory mechanism for potential anticancer applications, the fungus is documented as a human neurotoxin, with ingestion causing delayed-onset neurotoxic syndrome, hepatotoxicity, and nephrotoxicity in all reported poisoning cases.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordHapalopilus rutilans polyporic acid
Cinnamon Bracket Fungus — botanical close-up
Health Benefits
**DHODH Inhibition (Preclinical Interest)**
Polyporic acid's inhibition of dihydroorotate dehydrogenase suppresses de novo pyrimidine synthesis, a pathway exploited in cancer and autoimmune research; this mechanism mirrors that of approved drugs such as leflunomide and brequinar, generating laboratory-level interest in the compound.
**Antimicrobial Activity Against P
acnes**: Methanol extracts of H. rutilans demonstrated antimicrobial activity against Propionibacterium acnes with an MIC₅₀ of 128 μg/mL in in vitro testing, suggesting a potential topical anti-acne application if toxicity barriers can be resolved.
**Antifungal Potential (Hypothesized)**
The terphenyl quinone scaffold of polyporic acid has structural similarities to compounds with documented antifungal properties; however, no peer-reviewed studies have confirmed antifungal efficacy specifically for H. rutilans extracts in controlled assays.
**Pyrimidine Pathway Modulation**
By targeting DHODH, polyporic acid theoretically could limit nucleotide availability in hyperproliferative cells, a mechanism relevant to oncology research; this remains entirely preclinical and has not been translated to human therapeutic use.
**Natural Dye Compounds with Bioactive Properties**
The violet pigment produced upon alkaline treatment of polyporic acid represents a structurally unique chromophore whose bioactivity profile beyond DHODH inhibition has not been fully characterized, leaving open questions about secondary bioactive properties.
Origin & History
Natural habitat
Hapalopilus rutilans is a wood-rotting bracket fungus distributed across temperate deciduous and mixed forests of Europe and North America, typically fruiting on dead or dying hardwood trees including oak, beech, and willow. The fungus produces cinnamon-brown to ochre-colored, shelf-like fruit bodies and thrives in moist woodland environments from late summer through autumn. It is not commercially cultivated, and all documented specimens are collected from wild populations.
“Hapalopilus rutilans has no substantive documented history in any formal traditional medicine system — European, Asian, or Indigenous North American — and does not appear in classical herbals or materia medica texts as a medicinal agent. Its earliest scientific documentation relates to mycological taxonomy and the chemical isolation of polyporic acid in 1877, making it one of the earlier fungal natural products to be chemically characterized. The fungus achieved limited cultural recognition primarily through the natural dyeing community, where its striking violet color reaction with alkaline fixatives was appreciated by craftspeople working with botanical dyes. Poisoning events in the late twentieth and early twenty-first centuries elevated its profile in toxicological literature rather than in any therapeutic context.”Traditional Medicine
Scientific Research
The scientific literature on Hapalopilus rutilans is extremely limited and consists primarily of case reports, mycological descriptions, and in vitro biochemical studies rather than controlled clinical investigations. Two documented human poisoning cases (1992 and 2013, both from Germany) constitute the entirety of human exposure data, describing a consistent toxidrome of delayed neurotoxic syndrome with hepatorenal involvement and full recovery within approximately one week. A single peer-reviewed in vitro study identified the MIC₅₀ of methanol extract against Propionibacterium acnes at 128 μg/mL, and biochemical characterization of polyporic acid as a DHODH inhibitor has been established in enzyme-level assays. No preclinical animal pharmacology studies, pharmacokinetic analyses, dose-finding studies, or human clinical trials for any therapeutic indication have been published in indexed literature.
Preparation & Dosage
Traditional preparation
**Raw/Cooked Fruiting Body (Contraindicated)**
Consumption of fresh or cooked H. rutilans fruit bodies by humans is documented to cause serious poisoning; no safe dietary dose exists and ingestion in any quantity is contraindicated.
**Isolated Polyporic Acid (Research Use Only)**
Polyporic acid can be extracted via solvent methods for laboratory research; no standardized therapeutic preparation, dose, or formulation exists for human use.
**Methanol Extract (In Vitro Research)**
Antimicrobial testing used methanol extracts at concentrations yielding an MIC₅₀ of 128 μg/mL against P. acnes; this is a laboratory parameter only and does not correspond to a topical or oral therapeutic dose.
**Topical Exploration (Theoretical)**
Given the anti-acne in vitro data, topical formulation avoiding systemic absorption has been theoretically proposed but has not been developed, standardized, or safety-tested in vivo.
**Natural Dye Preparation (Non-Medicinal)**
Fruit bodies are used by natural dyers with alkaline mordants to produce violet pigments; this application involves no ingestion and represents the only documented non-toxic human use.
Nutritional Profile
Hapalopilus rutilans is not consumed as a food source due to its established toxicity, and no comprehensive nutritional analysis of its macronutrient or micronutrient composition has been published in peer-reviewed literature. Its most quantitatively significant phytochemical constituent is polyporic acid, a terphenyl para-quinone, present at 20–40% of dry fruit body weight — an exceptionally high concentration for a single secondary metabolite in a fungal species. Chitin-based structural polysaccharides typical of bracket fungi are presumed present in the cell walls, and beta-glucans common to basidiomycetes may occur, but their concentrations have not been reported. Bioavailability of polyporic acid after oral exposure is confirmed by its detection as violet-colored metabolites in urine following human poisoning, demonstrating gastrointestinal absorption and renal clearance.
How It Works
Mechanism of Action
Polyporic acid, the principal bioactive terphenyl quinone of Hapalopilus rutilans, functions as a competitive inhibitor of dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme catalyzing the fourth step of de novo pyrimidine biosynthesis — the oxidation of dihydroorotate to orotate. By blocking this enzymatic step, polyporic acid depletes intracellular pools of uridine monophosphate (UMP) and downstream pyrimidine nucleotides, impairing DNA and RNA synthesis in cells dependent on de novo synthesis rather than salvage pathways. This same mechanism underlies the toxicity profile of the fungus in vivo, as mammalian neurons, hepatocytes, and renal tubular cells with high nucleotide turnover are disproportionately affected, consistent with the observed neurotoxic, hepatotoxic, and nephrotoxic outcomes in poisoning cases. The characteristic violet discoloration of urine in poisoned individuals reflects renal excretion of polyporic acid metabolites, confirming systemic absorption and biotransformation.
Clinical Evidence
There are no clinical trials of Hapalopilus rutilans or isolated polyporic acid for any therapeutic indication in humans. The available human data derive exclusively from two accidental poisoning case reports spanning 1992 to 2013, which documented neurotoxic delayed syndrome, transient liver enzyme elevation, transient renal impairment, and full recovery in all affected individuals. No efficacy endpoints, therapeutic dose ranges, or safety margins have been established through prospective or controlled study designs. Confidence in any therapeutic application is extremely low, and the compound's established human toxicity profile represents a significant barrier to clinical translation without substantial pharmaceutical development and detoxification research.
Safety & Interactions
Hapalopilus rutilans is a confirmed human neurotoxin; ingestion of any quantity of the fruiting body causes a characteristic delayed-onset toxidrome appearing approximately 12 hours post-consumption, including nausea, ataxia, visual disturbances, and liver and kidney dysfunction, collectively termed neurotoxic delayed syndrome. Polyporic acid's inhibition of DHODH creates pharmacological overlap with immunosuppressant and antiproliferative drugs targeting the same enzyme (e.g., leflunomide, teriflunomide, brequinar), and concurrent use would theoretically produce additive DHODH suppression with unpredictable toxic amplification. The fungus is absolutely contraindicated during pregnancy and lactation, in individuals with hepatic or renal impairment, and in all pediatric populations; no maximum safe ingestion dose has been established because no safe dose has been identified. A distinctive diagnostic marker of poisoning is temporary violet discoloration of urine, which should prompt immediate medical evaluation and supportive care.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Hapalopilus rutilans (Berk.) P. Karst.Cinnamon BracketPolyporus rutilansHapalopilus nidulansTawny Crust Fungus
Frequently Asked Questions
Is Hapalopilus rutilans safe to eat or use as a supplement?
No — Hapalopilus rutilans is a documented human neurotoxin and is not safe to eat or consume in any form. Ingestion causes a delayed neurotoxic syndrome with symptoms including ataxia, visual impairment, and liver and kidney failure appearing approximately 12 hours after consumption, and no safe therapeutic dose has been established.
What is polyporic acid and why is it of interest in cancer research?
Polyporic acid is a terphenyl para-quinone compound comprising 20–40% of the dry weight of H. rutilans fruit bodies, first isolated in 1877. It inhibits dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme essential for de novo pyrimidine synthesis in rapidly proliferating cells — the same enzymatic target as several investigational anticancer drugs — generating preclinical interest in the compound despite its human toxicity.
What happens if you accidentally eat Hapalopilus rutilans mushrooms?
Accidental ingestion of H. rutilans produces a characteristic delayed-onset toxidrome beginning approximately 12 hours after consumption, including nausea, impaired coordination, visual disturbances, and biochemical evidence of liver and kidney damage. A distinctive clinical sign is temporary violet discoloration of the urine due to renal excretion of polyporic acid metabolites; both documented human poisoning cases (1992 and 2013) resulted in full recovery within approximately one week with supportive care.
Does Hapalopilus rutilans have any proven antimicrobial benefits?
In vitro laboratory testing of a methanol extract of H. rutilans demonstrated antimicrobial activity against Propionibacterium acnes (the bacterium associated with acne) with an MIC₅₀ of 128 μg/mL. This finding is preliminary and has not been replicated in animal models or human trials, and the known systemic toxicity of the fungus means this antimicrobial application cannot currently be safely developed without significant pharmaceutical processing.
Why does Hapalopilus rutilans turn urine purple?
The violet discoloration of urine observed in H. rutilans poisoning cases results from the renal excretion of polyporic acid and its alkaline-reactive metabolites, which form intensely pigmented violet quinone derivatives in the alkaline environment of urine. This color change, confirmed in both documented human poisoning cases, serves as a diagnostically useful clinical marker indicating systemic absorption of polyporic acid and warrants immediate medical evaluation.
Does Hapalopilus rutilans interact with leflunomide or other immunosuppressant medications?
Since polyporic acid from Hapalopilus rutilans inhibits DHODH through the same mechanism as leflunomide, concurrent use could potentiate immunosuppression and increase the risk of adverse effects. Individuals taking leflunomide, brequinar, or other DHODH-inhibiting drugs should consult a healthcare provider before using Hapalopilus rutilans supplements. Clinical data on this specific interaction is limited, making medical supervision essential.
Is Hapalopilus rutilans safe to use during pregnancy or while breastfeeding?
There is insufficient safety data on Hapalopilus rutilans use during pregnancy or lactation, and the immunomodulatory effects of polyporic acid have not been studied in these populations. Due to the potential for DHODH inhibition to affect fetal development (de novo pyrimidine synthesis is critical for cell division), pregnant and breastfeeding individuals should avoid this supplement without explicit medical clearance. Conservative caution is warranted until rigorous human safety studies are completed.
What does the current scientific evidence say about Hapalopilus rutilans effectiveness in humans versus laboratory studies?
Most evidence for Hapalopilus rutilans comes from in vitro and preclinical studies showing polyporic acid's DHODH inhibition and antimicrobial activity against pathogens like P. acnes; however, human clinical trials are sparse or absent. The gap between laboratory findings and proven human efficacy remains substantial, meaning marketed health claims often exceed the strength of clinical evidence. Any supplementation should be approached cautiously, recognizing that laboratory promise does not guarantee clinical benefit.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w hapalopilus-rutilans-hapalopilus-rutilans-berk-p-karst curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
